Skip to content

AvT PHARMA

Active Risk: not assessed
Private limited companyfounded 2024active for 2 yearsBrusselbaan 134, 1790 Affligem, BelgiumKBO/BCE: BE 1004.935.935

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
22-06
NBB filing Annual accounts 2025 filedNBB
abbreviated format · 39 days before the deadline
2025
31-12
Financial Equity above €100,000equity €134,018 ▲56.2%
With a profit in every financial year since 2024, equity grows to €134,018.
24-06
NBB filing Annual accounts 2024 filedPDF
abbreviated format · 37 days before the deadline
2024
23-01
Gazette deed Incorporation
Starting capital €50,000 · Appointment: VAN TICHELEN Ann (director) · Founder9 points ▸
  • Incorporation, “AvT PHARMA” (deed in Dutch)
  • Founder, VAN TICHELEN Ann
  • Founding capital, €50,000
  • Bank account, “BE09 6451 0962 1957, bewaard in dossier notaris” (deed in Dutch)
  • Other provision, “volstorting inbrengen”, EUR (deed in Dutch)
  • Other provision, “boeking inbreng, beschikbare eigen vermogensrekening van de vennootschap” (deed in Dutch)
  • Registered office clause, “1790 Affligem, Brusselbaan 134” (deed in Dutch)
  • Director appointment, VAN TICHELEN Ann (director)
  • Other provision, “aandelenregister en UBO, vanuit register automatisch” (deed in Dutch)

Open the act in the Belgian Official Gazette

Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

AvT PHARMA was incorporated on 19 January 2024 as a private limited company by one natural person, with a starting capital of €50,000.12 Since 2024, VAN TICHELEN Ann has served as director.3 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 23-01-2024
  3. 3National Bank, annual accounts 2025

Next steps